Efficacy Study of Subcutaneous Methyl-B12 in Children With Autism

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Autistic Disorder

In brief

We will be testing a specific dietary supplement, methylcobalamin (vitamin B12). Follow-up assessments with our clinical team will take place over the 12-week study period so that we can record any changes in development. The main goal of this study is to determine if subcutaneous injections of vitamin B12 given every three days can positively affect behavior and development in children with autism. Hypothesis: Methylcobalamin injections will improve measures of executive function, speech, and socialization in children with autism, and will be associated with metabolic improvement.

Key facts

Study ID

NCT00273650

Run by

University of California, San Francisco

People needed

30

Starts

2005-07-01

Expected to finish

2009-08-01

Last updated by the study team

2019-10-09

Who can join

Age: 3 and older, up to 8. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of DSM IV defined autism and meets cut off on Autism Diagnostic Inventory-Revised (ADI-R) and the Autism Diagnostic Observation Scale (ADOS).
• Age 3 to 8 years
• IQ of 50 or above
• Willingness of parents to administer subcutaneous methyl B12.
• Parental agreement to continue present dietary, behavioral or psychotropic drug treatment but not change treatment during 12 week intervention or wait list.

You may not qualify if…

• Clinical evidence of seizure disorder
• Cancer
• Recent surgery
• Active infection with fever
• Fragile X or other known genetic cause of autism
• Bleeding disorder
• Perinatal brain injury (e.g. cerebral palsy)
• Current use of any methyl B12 product
• Evidence for malnutrition seen in abnormal albumin level

Where it is running

• UC Davis MIND Institute — Sacramento, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.